2022 UPDATE CKD GUIDELINE 06092022

["Vascular access","","Statements: Education on ESKD Modalities and Dialysis Access 6.1 KDOQI considers it reasonable for adult and pediatric patients with an eGFR \u226430 mL\/min\/1.73 m2 (CKD G4) with progressive decline in kidney function to be educated on all modalities of kidney replacement therapy (KRT) options, including transplantation, so that timely referral can be made for the appropriate modality and creation of a functional dialysis access, if necessary. (Expert Opinion)","Statement: Vessel Preservation 6.10 KDOQI considers it reasonable to protect all central and peripheral arteries and veins from damage whenever possible, including the avoidance of peripherally inserted catheters and unnecessary venipunctures, for patients on dialysis or with CKD where dialysis access is expected in the future (CKD G3- G5). (Expert Opinion)","Non dialysis CKD Patients 6.6 KDOQI considers it reasonable that in nondialysis CKD patients with progressive decline in kidney function, referral for dialysis access assessment and subsequent creation should occur when eGFR is 15-20 mL\/min\/1.73 m2 . Earlier referral should occur in patients with unstable and\/or rapid rates of eGFR decline (eg, >10 mL\/min\/year). (Expert Opinion)","Statements: Vascular Access for Incident Patients 2.3 KDOQI suggests an AV access (AVF or AVG) in preference to a CVC in most incident and prevalent HD patients due to the lower infection risk associated with AV access use. (Conditional Recommendation, Low Quality of Evidence) 2.4 KDOQI considers it reasonable that the choice of AV access (AVF or AVG) be based on the operator\u2019s\/clinician\u2019s best clinical judgment that considers the vessel characteristics, patient comorbidities, health circumstances, and patient preference. (Expert Opinion)","My presentation","All you need to know about managing Chronic Kidney Disease","CKD-Management Strategy"]